Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

20262 citationsJournal Articlehybrid Open Access

Authors

Johnson & Johnson, Legend Biotech USA.

Published in: The Lancet Oncology

Volume 27, Issue 2, pp. 254-268

Field-Weighted Citation Impact: 97.11